home > ebr > > strategy for uk life sciences


Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.


Industry Events

DIA Annual Clinical Forum

14-15 April 2015, Paris, France

The 27th DIA Clinical Forum 2015, held in Paris from 14 – 15 April offers the ideal venue for professionals seeking to understand the professional implications of the changing European research environment.
More info >>

News and Press Releases

Novartis Lung Cancer Drug Zykadia™ Recommended for EU Approval in Patients With ALK+ NSCLC

Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion for Zykadia® (ceritinib) to treat adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement